Cytek Biosciences, Inc. (CTKB)
CTKBNASDAQ-GSBiotechnology: Laboratory Analytical Instruments
$5.89
+0.0600 (+1.03%) today
Closed, Nov 9, 4:00 PM ET
- Market cap
- $770.32m
- P/E
- –
- EPS, last 4 quarters
- $-0.3300
- Dividend yield
- –
- Day range
- –
- 52-week range
- $3.31 to $6.34
- Average volume
- 1.34m
- Previous close
- $5.83
Analysts
4 coveringBuy2 buy, 2 hold, 0 sell
Targets a year out average $5.88, -0.2% from here
Earnings
next estimate $-0.0400Next report
Dec 2025
0.0%
Mar 2026
-36.4%
Jun 2026
-50.0%
Sep 2026
+37.5%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $62.14m | $44.13m | $48.14m | $53.23m |
| Gross profit | $32.88m | $21.25m | $28.34m | $31.21m |
| Operating income | -$5.59m | -$18.46m | -$11.40m | -$8.42m |
| Net income | -$44.08m | -$18.87m | -$12.16m | -$6.10m |
Last four quarters: revenue $207.65m, margin -39.1%, free cash flow -$13.48m
News
8 latest- Cytek Biosciences (CTKB) Q3 2026 Earnings Call TranscriptThe Motley Fool · 5 days ago
- Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue EstimatesZacks · 5 days ago
- Cytek Biosciences Q3 Earnings Call HighlightsMarketBeat · 5 days ago
- Novavax (NVAX) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks · Oct 29, 2026
- Analysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out forZacks · Oct 28, 2026
- Cytek BioSciences Inc Reaches Analyst Target PriceBNK Invest · Sep 23, 2026
- Is the Options Market Predicting a Spike in Cytek Biosciences Bank Stock?Zacks · Sep 17, 2026
- Cytek (CTKB) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 12, 2026
The company
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Cytek's novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek's platform includes: its core FSP instruments, the Cytek Aurora, Northern Lights, Cytek Aurora CS and Cytek Aurora Evo systems; the Muse Micro system; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometers and imaging products under the Amnis and Guava brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers.
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- cytekbio.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.